Kluver Memorial Symposium: Biomarkers and Clinical Trials in Neurovascular Disease
Learning Objectives and Target Audience
At the conclusion of this activity, the learner will be able to:
- Describe trial design, including novel Bayesian methods, applicable to Phase I and II trials of rare diseases;
- State the categories of biomarkers, their analytic and clinical validation, and potential certification;
- Discuss strategies for deploying biomarkers and novel trial designs in specific neurovascular diseases;
- Recall newly funded NIND/NIH initiatives in trial readiness and proof of concept trial applied to cavernous angiomas with symptomatic hemorrhage (CASH).
Agenda subject to change.
Click here to learn more about the Gleacher Center!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-702-5595 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Section Chief of Neurosurgery
The University of Chicago
Issam Awad, MD
John Harper Seeley Professor of Surgery
Director, Neurovascular Surgery
Director, Safadi Program of Excellence in Clinical and Translational Neuroscience
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Claiming Credit: Enter the access code to unlock the credit claiming process.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.